Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.60 |
| ▸ | THPO | P40225 | 1/20 | 0.60 |
| ▸ | LCK | P06239 | 1/20 | 0.60 |
| ▸ | FYN | P06241 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.39 |
| ▸ | LDHB | P07195 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyruvate SCHEMBL1750 | 1.00 | — | — | |
| Pyruvate SCHEMBL13165964 | 1.00 | — | — | |
| Pyruvate SCHEMBL300872 | 1.00 | — | — | |
| Pyruvate SCHEMBL30036647 | 1.00 | — | — | |
| Pyruvate SCHEMBL8710301 | 1.00 | TSHR (0.60) | TSHRFFAR3THPOLCKFYN | |
| Pyruvate SCHEMBL23829857 | 1.00 | — | — | |
| Pyruvate SCHEMBL29358755 | 1.00 | — | — | |
| Pyruvate SCHEMBL8710299 | 1.00 | — | — | |
| Pyruvate SCHEMBL1331078 | 1.00 | — | — | |
| Pyruvate SCHEMBL10425930 | 1.00 | TSHR (0.60) | TSHRFFAR3THPOLCKFYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4553065-A2 | NOVEL COMPOUNDS FOR TREATING MITOCHONDRIAL DISEASE | KHONDRION IP B.V. (NL) | 2025-05-14 | — | — | EP | claimed |
| EP-4551234-A1 | REDOX-MODULATING ORGANELLE COMPLEXES | LUCA Science Inc. (JP) | 2025-05-14 | — | — | EP | claimed |
| CN-119654153-A | Redox-mediated organelle complex | 卢卡科学株式会社 | 2025-03-18 | — | — | CN | claimed |
| CN-118406638-A | Preparation method of optimized deer special-purpose in-vitro semen | 辽宁省农业发展服务中心 | 2024-07-30 | — | — | CN | claimed |
| US-20240059735-A1 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES | STEALTH BIOTHERAPEUTICS INC. (US) | 2024-02-22 | — | — | US | claimed |
| WO-2024010866-A1 | REDOX-MODULATING ORGANELLE COMPLEXES | Luca Science Inc. (JP) | 2024-01-11 | — | — | WO | claimed |
| US-20240000758-A1 | ELEVATION OF MITOCHONDRIAL BIOGENESIS AND FUNCTION BY INHIBITION OF PROSTAGLANDIN DEGRADING ENZYME 15-PGDH | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-01-04 | — | — | US | claimed |
| CN-117205298-A | Compositions and methods for preventing and treating mitochondrial myopathy | 康德生物医疗有限公司 | 2023-12-12 | — | — | CN | claimed |
| EP-4232026-A1 | ELEVATION OF MITOCHONDRIAL BIOGENESIS AND FUNCTION BY INHIBITION OF PROSTAGLANDIN DEGRADING ENZYME 15-PGDH | The Board of Trustees of the Leland Stanford Junior University (US) | 2023-08-30 | — | — | EP | claimed |
| US-11366104-B2 | Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening | STEALTH BIOTHERAPEUTICS INC. (US) | 2022-06-21 | — | — | US | claimed |
| EP-4000690-A1 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES | Stealth BioTherapeutics Inc. (US) | 2022-05-25 | — | — | EP | claimed |
| WO-2022087631-A1 | ELEVATION OF MITOCHONDRIAL BIOGENESIS AND FUNCTION BY INHIBITION OF PROSTAGLANDIN DEGRADING ENZYME 15-PGDH | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2022-04-28 | — | — | WO | claimed |
| US-20220055975-A1 | REDOX-ACTIVE THERAPEUTICS FOR TREATMENT OF MITOCHONDRIAL DISEASES AND OTHER CONDITIONS AND MODULATION OF ENERGY BIOMARKERS | PTC THERAPEUTICS, INC. | 2022-02-24 | — | — | US | claimed |
| US-20110263720-A1 | SYNTHESIS OF ALPHA-TOCOPHEROLQUINONE DERIVATIVES, AND METHODS OF USING THE SAME | PENWEST PHARMACEUTICALS CO. (US) | 2011-10-27 | — | — | US | claimed |
| EP-1230209-B3 | STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES | UCB PHARMA GMBH (DE) | 2011-10-05 | — | — | EP | claimed |
| WO-2011112679-A1 | SYNTHESIS OF ALPHA-TOCOPHEROLQUINONE DERIVATIVES, AND METHODS OF USING THE SAME | PENWEST PHARMACEUTICALS CO. (US) | 2011-09-15 | — | — | WO | claimed |
| US-20110218208-A1 | 2-HETEROCYCLYLAMINOALKYL-(P-QUINONE) DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES | EDISON PHAMACEUTICALS, INC. | 2011-09-08 | — | — | US | claimed |
| EP-2303824-A1 | 2-HETEROCYCLYLAMINOALKYL-(P-QUINONE) DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES | Edison Pharmaceuticals, Inc. (US) | 2011-04-06 | — | — | EP | claimed |
| US-20110046219-A1 | (HET)ARYL-P-QUINONE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES | EDISON PHARMACEUTICALS, INC | 2011-02-24 | — | — | US | claimed |
| CN-121545750-B | Individual dynamic metabolism abnormality early warning system based on functional data analysis | Hangzhou Institute of advanced studies National University of science and technology (CN) | 2026-05-26 | — | — | CN | disclosed |
| EP-4739784-A1 | METHOD FOR PRODUCING AN AQUEOUS SOLUTION CONTAINING ETHYLENE GLYCOL | Annikki GmbH (AT) | 2026-05-13 | — | — | EP | disclosed |
| CN-112118855-B | Weight management composition | 爱瑟金股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-4735586-A1 | CELLULAR REPROGRAMMING | Samuel, Amy Jane (NZ) | 2026-05-06 | — | — | EP | disclosed |
| EP-4727448-A1 | OPTICAL CHEMICAL SENSOR SYSTEM WITH MICRONEEDLES | Cardiac Pacemakers, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260034177-A1 | HUMAN FUNCTIONAL CORNEAL ENDOTHELIAL CELL AND APPLICATION THEREOF | KYOTO PREFECTURAL PUBLIC UNIV CORP (JP) | 2026-02-05 | — | — | US | disclosed |
| CN-120138753-A | Porous TiO capable of reviving macrophage mitochondrial function and further promoting macrophage M2 polarization2Coating and preparation method thereof | 中国人民解放军空军军医大学 | 2025-06-13 | — | — | CN | disclosed |
| EP-4560006-A1 | AQUARIUM PRESSURE GAS TANK CO2 GENERATING COMPOSITION, AQUARIUM PRESSURE GAS TANK CO2 GENERATING COMPOSITION PACKAGE, AND AQUARIUM PRESSURE GAS TANK | Sunbau GmbH (DE) | 2025-05-28 | — | — | EP | disclosed |
| EP-4553065-A2 | NOVEL COMPOUNDS FOR TREATING MITOCHONDRIAL DISEASE | KHONDRION IP B.V. (NL) | 2025-05-14 | — | — | EP | disclosed |
| EP-4551234-A1 | REDOX-MODULATING ORGANELLE COMPLEXES | LUCA Science Inc. (JP) | 2025-05-14 | — | — | EP | disclosed |
| CN-119931977-A | Enzyme composition, product and application thereof in preparation of ectoin | 深圳瑞德林生物技术有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-119901790-A | Flexible degradable lactic acid sensor and preparation method and application thereof | 清华大学 | 2025-04-29 | — | — | CN | disclosed |
| CN-119907662-A | Fast dissolving soft gel capsule | R·P·谢勒技术有限公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-119464188-B | Application of Forskolin in promotion of synthesis of sialic acid by mammary epithelial cells | 北京三元食品股份有限公司 | 2025-04-29 | — | — | CN | disclosed |
| EP-3359521-B1 | NOVEL COMPOUNDS FOR TREATING MITOCHONDRIAL DISEASE | KHONDRION IP B V (NL) | 2025-04-16 | — | — | EP | disclosed |
| CN-119816301-A | Enteric coated soft gel capsule | R·P·谢勒技术有限公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-114702406-B | Polymorphic and amorphous forms of a compound | PTC医疗公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-119464188-A | Application of Forskolin in promotion of synthesis of sialic acid by mammary epithelial cells | 北京三元食品股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| WO-2025012222-A1 | METHOD FOR PRODUCING AN AQUEOUS SOLUTION CONTAINING ETHYLENE GLYCOL | ANNIKKI GMBH (AT) | 2025-01-16 | — | — | WO | disclosed |
| EP-4488374-A1 | PROCESS FOR PREPARING AN AQUEOUS SOLUTION COMPRISING ETHYLENE GLYCOL | Annikki GmbH (AT) | 2025-01-08 | — | — | EP | disclosed |
| CN-119193574-A | Method for screening oleaginous microalgae by combining inhibitor and plasma mutagenesis | 江西理工大学 | 2024-12-27 | — | — | CN | disclosed |
| US-20240415418-A1 | OPTICAL CHEMICAL SENSOR SYSTEM WITH MICRONEEDLES | CARDIAC PACEMAKERS, INC. | 2024-12-19 | — | — | US | disclosed |
| WO-2024258781-A1 | OPTICAL CHEMICAL SENSOR SYSTEM WITH MICRONEEDLES | CARDIAC PACEMAKERS, INC. (US) | 2024-12-19 | — | — | WO | disclosed |
| US-20240415417-A1 | OPTICAL CHEMICAL SENSOR SYSTEM WITH MICRONEEDLES | CARDIAC PACEMAKERS, INC. | 2024-12-19 | — | — | US | disclosed |
| CN-119144633-A | Method for regulating and controlling prpB gene promoter expression intensity | 天津科技大学 | 2024-12-17 | — | — | CN | disclosed |
| US-20240390321-A1 | Treatment of mitochondrial diseases | KHONDRION IP B.V. (NL) | 2024-11-28 | — | — | US | disclosed |
| CN-119007849-A | Method and system for forecasting concentration of microbial fermentation process product based on mechanism model | 上海交通大学 | 2024-11-22 | — | — | CN | disclosed |
| CN-118995922-A | TRF related to non-small cell lung cancer and application thereof | 深圳大学 | 2024-11-22 | — | — | CN | disclosed |
| CN-117625585-B | Bifunctional enzyme NagEA and application thereof | 珠海瑞德林生物有限公司 | 2024-10-25 | — | — | CN | disclosed |
| CN-118804980-A | Microorganism producing 1, 4-butanediol and method for producing 1, 4-butanediol using the same | 大象株式会社 | 2024-10-18 | — | — | CN | disclosed |
| CN-113984822-B | Quality control method and application of Shuxuetong injection based on nuclear magnetic resonance technology | 牡丹江友搏药业有限责任公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-118604356-A | Noninvasive diagnosis biomarker combination for prostate cancer risk stratification and application thereof | 温州医科大学 | 2024-09-06 | — | — | CN | disclosed |
| CN-118516320-A | D-lactate dehydrogenase mutant, preparation method, encoding DNA and D-lactate production method and application thereof | 上海交通大学 | 2024-08-20 | — | — | CN | disclosed |
| CN-118406638-A | Preparation method of optimized deer special-purpose in-vitro semen | 辽宁省农业发展服务中心 | 2024-07-30 | — | — | CN | disclosed |
| CN-118406638-A | Preparation method of optimized deer special-purpose in-vitro semen | 辽宁省农业发展服务中心 | 2024-07-30 | — | — | CN | disclosed |
| CN-118355110-A | Method for producing cartilage and bone | 默多克儿童研究所 | 2024-07-16 | — | — | CN | disclosed |
| US-12004853-B2 | Systems and methods for disambiguation of posture | CARDIAC PACEMAKERS, INC. (US) | 2024-06-11 | — | — | US | disclosed |
| CN-118086453-A | Application of glutamate dehydrogenase and glutamate-pyruvate transaminase circulating reaction system in method for detecting enzyme activity and enzyme substrate | 南京盛德瑞尔医药科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| EP-4368720-A1 | PROCESS FOR PRODUCING AQUEOUS SOLUTION CONTAINING GLYCERIN | Annikki GmbH (AT) | 2024-05-15 | — | — | EP | disclosed |
| EP-3733642-B1 | 4-(P-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES | PTC THERAPEUTICS INC (US) | 2024-05-08 | — | — | EP | disclosed |
| US-11938101-B2 | Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide | PTC THERAPEUTICS, INC. (US) | 2024-03-26 | — | — | US | disclosed |
| CN-117751192-A | Recombinant microorganism for producing 2, 3-butanediol with reduced by-product production and method for producing 2, 3-butanediol using the same | GS加德士 | 2024-03-22 | — | — | CN | disclosed |
| CN-110892073-B | Enhanced metabolite producing yeast | 安迪苏法国联合股份有限公司 | 2024-03-01 | — | — | CN | disclosed |
| US-20240059735-A1 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES | STEALTH BIOTHERAPEUTICS INC. (US) | 2024-02-22 | — | — | US | disclosed |
| WO-2024010866-A1 | REDOX-MODULATING ORGANELLE COMPLEXES | Luca Science Inc. (JP) | 2024-01-11 | — | — | WO | disclosed |
| US-20240000758-A1 | ELEVATION OF MITOCHONDRIAL BIOGENESIS AND FUNCTION BY INHIBITION OF PROSTAGLANDIN DEGRADING ENZYME 15-PGDH | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-01-04 | — | — | US | disclosed |
| CN-117264918-A | GNA1 enzyme, fusion protein, nucleic acid, recombinant vector, genetically engineered bacterium, method and application thereof | 上海交通大学 | 2023-12-22 | — | — | CN | disclosed |
| CN-117205298-A | Compositions and methods for preventing and treating mitochondrial myopathy | 康德生物医疗有限公司 | 2023-12-12 | — | — | CN | disclosed |
| US-11840497-B2 | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | PTC THERAPEUTICS, INC. (US) | 2023-12-12 | — | — | US | disclosed |
| CN-117122587-A | Use of pyruvate in the treatment of lipodystrophy syndrome | 上海市内分泌代谢病研究所 | 2023-11-28 | — | — | CN | disclosed |
| US-20230364029-A1 | POLYMORPHIC FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)BUTANAMIDE | PTC THERAPEUTICS INC (US) | 2023-11-16 | — | — | US | disclosed |
| CN-117004633-A | Recombinant strain for producing sodium vibrio pyruvic acid as well as construction method and application thereof | 中国科学院天津工业生物技术研究所 | 2023-11-07 | — | — | CN | disclosed |
| CN-116987781-A | Biomarker for detecting mitochondrial diseases of children and application thereof | 浙江省人民医院 | 2023-11-03 | — | — | CN | disclosed |
| CN-116970619-A | Application of exocarpium Citri Grandis transcription factor CgWRKY40 gene in regulation and control of monoterpene biosynthesis | 广东省农业科学院果树研究所 | 2023-10-31 | — | — | CN | disclosed |
| EP-3672486-B1 | IMPLANTABLE CHEMICAL SENSOR WITH STAGED ACTIVATION | CARDIAC PACEMAKERS INC (US) | 2023-10-25 | — | — | EP | disclosed |
| WO-2023184822-A1 | ENZYME CO-EXPRESSION SYSTEM AND USE THEREOF IN SYNTHESIS OF SIALIC ACID | 深圳瑞德林生物技术有限公司 | 2023-10-05 | — | — | WO | disclosed |
| CN-109864746-B | Multimode analyte sensor for medical devices | 心脏起搏器股份公司 | 2023-09-29 | — | — | CN | disclosed |
| EP-4241842-A2 | NOVEL TREATMENT OF MITOCHONDRIAL DISEASES | KHONDRION IP B.V. (NL) | 2023-09-13 | — | — | EP | disclosed |
| EP-3983385-B1 | NAPHTHOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS | PTC THERAPEUTICS INC (US) | 2023-08-30 | — | — | EP | disclosed |
| EP-4232026-A1 | ELEVATION OF MITOCHONDRIAL BIOGENESIS AND FUNCTION BY INHIBITION OF PROSTAGLANDIN DEGRADING ENZYME 15-PGDH | The Board of Trustees of the Leland Stanford Junior University (US) | 2023-08-30 | — | — | EP | disclosed |
| CN-109864747-B | Multimode analyte sensor optoelectronic interface | 心脏起搏器股份公司 | 2023-08-25 | — | — | CN | disclosed |
| EP-4218773-A1 | HUMAN FUNCTIONAL CORNEAL ENDOTHELIAL CELL AND APPLICATION THEREOF | Kyoto Prefectural Public University Corporation (JP) | 2023-08-02 | — | — | EP | disclosed |
| CN-116457014-A | Mitochondrial biosynthesis and function enhancement by inhibition of prostaglandin degrading enzyme 15-PGDH | 莱兰斯坦福初级大学评议会 | 2023-07-18 | — | — | CN | disclosed |
| EP-3606522-B1 | NOVEL TREATMENT OF MITOCHONDRIAL DISEASES | KHONDRION IP B V (NL) | 2023-07-12 | — | — | EP | disclosed |
| US-11680034-B2 | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders | PTC THERAPEUTICS, INC. (US) | 2023-06-20 | — | — | US | disclosed |
| CN-116240155-A | Recombinant bacterium for producing poly (hydroxy fatty acid-co-lactic acid) and application thereof | 清华大学 | 2023-06-09 | — | — | CN | disclosed |
| CN-116183788-A | Method for analyzing TCA (ternary content addressable memory) cycle by combining isotope tracing technology with high-resolution mass spectrum | 中国农业大学 | 2023-05-30 | — | — | CN | disclosed |
| WO-2023079430-A1 | METHODS OF TREATING MITOCHONDRIAL MYOPATHIES USING ANTI-GDF15 ANTIBODIES | PFIZER INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| CN-116096908-A | Method for preparing guanidinoacetic acid by fermentation | 赢创运营有限公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-115884766-A | Methods for treating infantile spasms using medium chain triglycerides | 睿升公司 | 2023-03-31 | — | — | CN | disclosed |
| CN-109419515-B | Implantable chemical sensor with staged activation | 心脏起搏器股份公司 | 2023-03-24 | — | — | CN | disclosed |
| EP-3416658-B1 | HUMAN FUNCTIONAL CORNEAL ENDOTHELIAL CELL AND APPLICATION THEREOF | KYOTO PREFECTURAL PUBLIC UNIV CORP (JP) | 2023-03-22 | — | — | EP | disclosed |
| CN-115803442-A | Method for preparing guanidinoacetic acid by fermentation | 赢创运营有限公司 | 2023-03-14 | — | — | CN | disclosed |
| EP-3440999-B1 | SYSTEMS INCLUDING ELECTROLYTE SENSOR FUSION | CARDIAC PACEMAKERS INC (US) | 2023-03-08 | — | — | EP | disclosed |
| US-11571151-B2 | Implantable chemical sensor with staged activation | CARDIAC PACEMAKERS, INC. (US) | 2023-02-07 | — | — | US | disclosed |
| CN-115606808-A | Dietary composition useful for preventing and controlling obesity | 崔明奭 | 2023-01-17 | — | — | CN | disclosed |
| CN-115606806-A | Dietary composition useful for preventing and controlling obesity | 崔明奭 | 2023-01-17 | — | — | CN | disclosed |
| CN-115606807-A | Dietary composition useful for preventing and controlling obesity | 崔明奭 | 2023-01-17 | — | — | CN | disclosed |
| CN-109381195-B | Systems and methods including electrolyte sensor fusion | 心脏起搏器股份公司 | 2023-01-10 | — | — | CN | disclosed |
| US-20230002324-A1 | NAPHTHOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS | PTC THERAPEUTICS, INC. | 2023-01-05 | — | — | US | disclosed |
| US-11530190-B2 | Compounds for treating mitochondrial disease | KHONDRION IP B.V. (NL) | 2022-12-20 | — | — | US | disclosed |
| CN-113514531-B | Fragment ion prediction method and application of compound | 清华大学 | 2022-10-25 | — | — | CN | disclosed |
| EP-3492014-B1 | MULTIMODAL ANALYTE SENSORS FOR MEDICAL DEVICES | CARDIAC PACEMAKERS INC (US) | 2022-10-19 | — | — | EP | disclosed |
| CN-115175739-A | Personal care compositions | 高露洁-棕榄公司 | 2022-10-11 | — | — | CN | disclosed |
| EP-4059922-A1 | POLYMORPHIC AND AMORPHOUS FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)BUTANAMIDE | PTC Therapeutics, Inc. (US) | 2022-09-21 | — | — | EP | disclosed |
| US-11439304-B2 | Systems and methods including electrolyte sensor fusion | CARDIAC PACEMAKERS, INC. (US) | 2022-09-13 | — | — | US | disclosed |
| CN-114949051-A | Use of plum extract for preparing composition for improving body function | 百岳特生物技术（上海）有限公司 | 2022-08-30 | — | — | CN | disclosed |
| US-20220265578-A1 | POLYMORPHIC AND AMORPHOUS FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)BUTANAMIDE | BIOELECTRON TECHNOLOGY CORPORATION | 2022-08-25 | — | — | US | disclosed |
| US-20220265604-A1 | Treatment of mitochondrial diseases | KHONDRION IP B.V. (NL) | 2022-08-25 | — | — | US | disclosed |
| CN-114678133-A | Thyroid cancer RAI-R risk prediction method, system, equipment and medium | 上海市第十人民医院 | 2022-06-28 | — | — | CN | disclosed |
| US-11366104-B2 | Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening | STEALTH BIOTHERAPEUTICS INC. (US) | 2022-06-21 | — | — | US | disclosed |
| CN-114585361-A | Oral pharmaceutical composition for treating liver cancer | 艾特诺瓦治疗公司 | 2022-06-03 | — | — | CN | disclosed |
| EP-4000690-A1 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES | Stealth BioTherapeutics Inc. (US) | 2022-05-25 | — | — | EP | disclosed |
| EP-3495804-B1 | IMPLANTABLE MULTIMODAL OPTOELECTRONIC ANALYTE SENSOR | CARDIAC PACEMAKERS INC (US) | 2022-05-11 | — | — | EP | disclosed |
| CN-112525966-B | Based on H2O2Non-enzyme pyruvic acid sensing detection method | 南京工业大学 | 2022-05-06 | — | — | CN | disclosed |
| US-20220133648-A1 | TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES | PTC THERAPEUTICS, INC. | 2022-05-05 | — | — | US | disclosed |
| WO-2022087631-A1 | ELEVATION OF MITOCHONDRIAL BIOGENESIS AND FUNCTION BY INHIBITION OF PROSTAGLANDIN DEGRADING ENZYME 15-PGDH | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2022-04-28 | — | — | WO | disclosed |
| EP-3983385-A1 | NAPHTHOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS | PTC Therapeutics, Inc. (US) | 2022-04-20 | — | — | EP | disclosed |
| US-11304914-B2 | Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide | PTC THERAPEUTICS, INC. (US) | 2022-04-19 | — | — | US | disclosed |
| CN-113355300-B | Aromatic isopentenyl transferase mutant, construction method of recombinant bacterium for expression of mutant and recombinant bacterium constructed by mutant | 深圳蓝晶生物科技有限公司 | 2022-04-01 | — | — | CN | disclosed |
| US-11285130-B2 | Treatment of mitochondrial diseases | KHONDRION IP B.V. (NL) | 2022-03-29 | — | — | US | disclosed |
| EP-3233786-B1 | POLYMORPHIC AND AMORPHOUS FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)BUTANAMIDE | PTC THERAPEUTICS INC (US) | 2022-03-16 | — | — | EP | disclosed |
| US-20220055975-A1 | REDOX-ACTIVE THERAPEUTICS FOR TREATMENT OF MITOCHONDRIAL DISEASES AND OTHER CONDITIONS AND MODULATION OF ENERGY BIOMARKERS | PTC THERAPEUTICS, INC. | 2022-02-24 | — | — | US | disclosed |
| WO-2021215852-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY AND TREATMENT METHOD USING SAME COMPOSITION | (주)셀트리온 (KR) | 2021-10-28 | — | — | WO | disclosed |
| US-11062794-B2 | Olfactory signature and odorant mixture having the same | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-07-13 | — | — | US | disclosed |
| CN-112415037-A | Based on1Method for identifying authenticity of powder at different parts of ginseng through H NMR metabonomics | 长春中医药大学 | 2021-02-26 | — | — | CN | disclosed |
| US-10576077-B2 | Pharmaceutical salt forms of Cepharanthine and Tetrandrine | SOUTHWEST RESEARCH INSTITUTE (US) | 2020-03-03 | — | — | US | disclosed |
| CN-106399135-B | One plant height is laid eggs white yeast strain C20140911 and its breeding, cultural method and application | 中国农业科学院兰州畜牧与兽药研究所 | 2019-08-20 | — | — | CN | disclosed |
| CN-109827985-A | It is a kind of based on NMR metabolism group to the discrimination method of maca different cultivars | 长春中医药大学 | 2019-05-31 | — | — | CN | disclosed |
| EP-3478848-A2 | METHODS AND MICROORGANISMS FOR PRODUCING FLAVORS AND FRAGRANCE CHEMICALS | Ardra Bio Inc. (US) | 2019-05-08 | — | — | EP | disclosed |
| CN-105671127-B | A kind of stable enzyme process serum Mg-ion detection kit | 王爰 | 2019-01-04 | — | — | CN | disclosed |
| US-20180303823-A1 | PHARMACEUTICAL SALT FORMS OF CEPHARANTHINE AND TETRANDRINE | SOUTHWEST RESEARCH INSTITUTE | 2018-10-25 | — | — | US | disclosed |
| US-20180253534-A1 | OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2018-09-06 | — | — | US | disclosed |
| WO-2018005806-A2 | METHODS AND MICROORGANISMS FOR PRODUCING FLAVORS AND FRAGRANCE CHEMICALS | ARDRA BIO INC. (US) | 2018-01-04 | — | — | WO | disclosed |
| CN-106399135-A | Protein high-yielding Saccharomyces cerevisiae C20140911, and breeding and culturing method and application thereof | 中国农业科学院兰州畜牧与兽药研究所 | 2017-02-15 | — | — | CN | disclosed |
| US-20160280716-A1 | PHARMACEUTICAL SALT FORMS OF CEPHARANTHINE AND TETRANDRINE | SOUTHWEST RES INST (US) | 2016-09-29 | — | — | US | disclosed |
| CN-101820753-B | Use of an inflammatory modulator in the manufacture of a medicament for treating a pulmonary disease state in a mammal | CELLULAR SCIENCES, INC. (US) | 2016-04-13 | — | — | CN | disclosed |
| EP-1838837-B1 | RECOMBINANT MICROORGANISMS FOR INCREASED PRODUCTION OF ORGANIC ACIDS | MICHIGAN BIOTECH INST (US) | 2015-04-15 | — | — | EP | disclosed |
| EP-2853602-A1 | Yeast cell with increased pyruvate pool in cytosol and method of producing pyruvate-based metabolite using the same | Samsung Electronics Co., Ltd (KR) | 2015-04-01 | — | — | EP | disclosed |
| US-20150087032-A1 | YEAST CELL WITH INCREASED PYRUVATE POOL IN CYTOSOL AND METHOD OF PRODUCING PYRUVATE-BASED METABOLITE USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-03-26 | — | — | US | disclosed |
| WO-2015035244-A1 | MODIFIED MICROORGANISM AND METHODS OF USING SAME FOR PRODUCING BUTADIENE AND 1-PROPANOL AND/OR 1,2-PROPANEDIOL | BRASKEM S/A (BR) | 2015-03-12 | — | — | WO | disclosed |
| WO-2015031504-A1 | RECOMBINANT PATHWAY AND ORGANISMS FOR MALONYL-CoA SYNTHESIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-03-05 | — | — | WO | disclosed |
| WO-2013187891-A1 | METHOD FOR TREATING A PULMONARY DISEASE STATE IN MAMMALS BY UP REGULATING INDIGENOUS IN VIVO LEVELS OF INFLAMMATORY AGENTS IN MAMMALIAN CELLS | MARTIN ALAIN (US) | 2013-12-19 | — | — | WO | disclosed |
| US-8431373-B2 | Recombinant microorganisms for increased production of organic acids | MICHIGAN BIOTECHNOLOGY INSTITUTE (US) | 2013-04-30 | — | — | US | disclosed |
| WO-2013035070-A1 | OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2013-03-14 | — | — | WO | disclosed |
| US-20120164703-A1 | RECOMBINANT MICROORGANISMS FOR INCREASED PRODUCTION OF ORGANIC ACIDS | MICHIGAN BIOTECHNOLOGY INSTITUTE (US) | 2012-06-28 | — | — | US | disclosed |
| EP-2460872-A1 | Recombinant microorganisms for increased production of organic acids | MICHIGAN BIOTECHNOLOGY INSTITUTE (US) | 2012-06-06 | — | — | EP | disclosed |
| US-20120094836-A1 | Biocide Compositions (III) | COGNIS IP MANAGEMENT GMBH (DE) | 2012-04-19 | — | — | US | disclosed |
| US-8152931-B2 | Dishwasher detergent with excellent rinsing power | BASF SE (DE) | 2012-04-10 | — | — | US | disclosed |
| US-8133714-B2 | Process for the fermentative preparation of organic chemical compounds using coryneform bacteria in which the SugR gene is present in attenuated form | EVONIK DEGUSSA GMBH (DE) | 2012-03-13 | — | — | US | disclosed |
| US-8126554-B2 | Implantable medical device with chemical sensor and related methods | CARDIAC PACEMAKERS, INC. (US) | 2012-02-28 | — | — | US | disclosed |
| US-8123867-B2 | Phosphate-free dishwasher detergent with excellent rinsing power | BASF SE (DE) | 2012-02-28 | — | — | US | disclosed |
| US-8119377-B2 | Recombinant microorganisms for increased production of organic acids | MICHIGAN BIOTECHNOLOGY INSTITUTE (US) | 2012-02-21 | — | — | US | disclosed |
| US-20120016446-A1 | Therapeutic electric antioxidant clothing apparatus and method | Integrity Research Institute (US) | 2012-01-19 | — | — | US | disclosed |
| US-8062429-B2 | Methods of cleaning semiconductor devices at the back end of line using amidoxime compositions | EKC TECHNOLOGY, INC. (US) | 2011-11-22 | — | — | US | disclosed |
| US-20110263720-A1 | SYNTHESIS OF ALPHA-TOCOPHEROLQUINONE DERIVATIVES, AND METHODS OF USING THE SAME | PENWEST PHARMACEUTICALS CO. (US) | 2011-10-27 | — | — | US | disclosed |
| WO-2011112679-A1 | SYNTHESIS OF ALPHA-TOCOPHEROLQUINONE DERIVATIVES, AND METHODS OF USING THE SAME | PENWEST PHARMACEUTICALS CO. (US) | 2011-09-15 | — | — | WO | disclosed |
| US-20110218208-A1 | 2-HETEROCYCLYLAMINOALKYL-(P-QUINONE) DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES | EDISON PHAMACEUTICALS, INC. | 2011-09-08 | — | — | US | disclosed |
| EP-2357245-A1 | Microbial production of alanine | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2011-08-17 | — | — | EP | disclosed |
| US-7989654-B2 | High purity bases of 3,3-diphenylpropylamino monoesters | UCB PHARMA GMBH (DE) | 2011-08-02 | — | — | US | disclosed |
| US-20110180747-A1 | Trioka Acid Semiconductor Cleaning Compositions and Methods of Use | LASERWORT LTD (HK) | 2011-07-28 | — | — | US | disclosed |
| EP-2348121-A1 | Microbial production of pyruvate | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2011-07-27 | — | — | EP | disclosed |
| US-20110172312-A1 | TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES | EDISON PHARMACEUTICALS, INC. | 2011-07-14 | — | — | US | disclosed |
| WO-2011082355-A1 | TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES | EDISON PHARMACEUTICALS, INC. (US) | 2011-07-07 | — | — | WO | disclosed |
| US-20110160151-A1 | Novel Acetates of 2-Deoxy Monosaccharides with Anticancer Activity | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-06-30 | — | — | US | disclosed |
| US-20110150917-A1 | Small Cationic Antimicrobial Peptides | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2011-06-23 | — | — | US | disclosed |
| EP-2332534-A1 | Phenol and benzoquinone derivatives for use in the treatment of mitochondrial diseases and modulation of energy biomarkers | Edison Pharmaceuticals, Inc. (US) | 2011-06-15 | — | — | EP | disclosed |
| US-20110124679-A1 | 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES | PTC THERAPEUTICS, INC. | 2011-05-26 | — | — | US | disclosed |
| US-7947130-B2 | Troika acid semiconductor cleaning compositions and methods of use | LASERWORT LTD (HK) | 2011-05-24 | — | — | US | disclosed |
| US-20110094536-A1 | Troika Acid Semiconductor Cleaning Compositions and Methods of Use | Lee, Wai Mun (US) | 2011-04-28 | — | — | US | disclosed |
| EP-2310020-A2 | NOVEL ACETATES OF 2-DEOXY MONOSACCHARIDES WITH ANTICANCER ACTIVITY | Board of Regents, The University of Texas System (US) | 2011-04-20 | — | — | EP | disclosed |
| US-20110086103-A1 | NOVEL MANDELATE SALT OF FESOTERODINE | ACTAVIS GROUP PTC EHF (IS) | 2011-04-14 | — | — | US | disclosed |
| EP-2303309-A2 | TREATMENT OF MITOCHONDRIAL DISEASES WITH AN ERYTHROPOIETIN MIMETIC | Edison Pharmaceuticals, Inc. (US) | 2011-04-06 | — | — | EP | disclosed |
| EP-2303824-A1 | 2-HETEROCYCLYLAMINOALKYL-(P-QUINONE) DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES | Edison Pharmaceuticals, Inc. (US) | 2011-04-06 | — | — | EP | disclosed |
| US-7919117-B2 | Drug delivery of fesoterodine (fumarate) through the skin in a dosage ofo.r-20 mg per day and is provided in a polymer matrix for uniform release;contact adhesives; sel-adhesives; impermeable backing; flatness; geratrics;drug delivery; side effect reduction | UCB PHARMA GMBH (DE) | 2011-04-05 | — | — | US | disclosed |
| US-20110065622-A1 | NOVEL NITRILE AND AMIDOXIME COMPOUNDS AND METHODS OF PREPARATION FOR SEMICONDUCTOR PROCESSING | EKC TECHNOLOGY, INC. | 2011-03-17 | — | — | US | disclosed |
| WO-2011026580-A2 | BIOCIDE COMPOSITIONS (IV) | COGNIS IP MANAGEMENT GMBH (DE) | 2011-03-10 | — | — | WO | disclosed |
| EP-2292092-A1 | Biocide compositions comprising esters of ketocarboxylic acids | Cognis IP Management GmbH (DE) | 2011-03-09 | — | — | EP | disclosed |
| US-20110046219-A1 | (HET)ARYL-P-QUINONE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES | EDISON PHARMACEUTICALS, INC | 2011-02-24 | — | — | US | disclosed |
| US-20110003758-A1 | Inhibitors of Glycolysis Useful In the Treatment of Brain Tumors | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-01-06 | — | — | US | disclosed |
| EP-2269451-A1 | Biocide compositions (III) | Cognis IP Management GmbH (DE) | 2011-01-05 | — | — | EP | disclosed |
| EP-2244553-A2 | GENETICALLY MODIFIED PHOTOAUTOTROPHIC ETHANOL PRODUCING HOST CELLS, METHOD FOR PRODUCING THE HOST CELLS, CONSTRUCTS FOR THE TRANSFORMATION OF THE HOST CELLS, METHOD FOR TESTING A PHOTOAUTOTROPHIC STRAIN FOR A DESIRED GROWTH PROPERTY AND METHOD OF PRODUCING ETHANOL USING THE HOST CELLS | Algenol Biofuels Inc. (US) | 2010-11-03 | — | — | EP | disclosed |
| US-20100266723-A1 | METHODS FOR FORMULATING AND CUSTOMIZING A MICRONUTRIENT SUPPLEMENT | METAMETRIX, INC. (US) | 2010-10-21 | — | — | US | disclosed |
| EP-2187738-A1 | METHOD FOR TREATING A PULMONARY DISEASE STATE IN MAMMALS BY UP OR DOWN REGULATING INDIGENOUS IN VIVO LEVELS OF INFLAMMATORY AGENTS IN MAMMALIAN CELLS | Cellular Sciences, Inc. (US) | 2010-05-26 | — | — | EP | disclosed |
| WO-2010019434-A1 | METHODS TO TREAT AND SCREEN FOR AGENTS TO TREAT OBESITY | TRUSTEES OF TUFTS COLLEGE (US) | 2010-02-18 | — | — | WO | disclosed |
| WO-2009098089-A2 | GENETICALLY MODIFIED PHOTOAUTOTROPHIC ETHANOL PRODUCING HOST CELLS, METHOD FOR PRODUCING THE HOST CELLS, CONSTRUCTS FOR THE TRANSFORMATION OF THE HOST CELLS, METHOD FOR TESTING A PHOTOAUTOTROPHIC STRAIN FOR A DESIRED GROWTH PROPERTY AND METHOD OF PRODUCING ETHANOL USING THE HOST CELLS | BAIER KERSTIN (DE) | 2009-08-13 | — | — | WO | disclosed |
| CN-101464405-A | Kalium ion diagnosis/measuring reagent kit and kalium ion concentration determination method | SUZHOU ANJ BIOTECH CO LTD (CN) | 2009-06-24 | — | — | CN | disclosed |
| CN-101464301-A | Kalium ion diagnosis/measuring reagent kit and kalium ion concentration determination method | SUZHOU ANJ BIOTECH CO LTD (CN) | 2009-06-24 | — | — | CN | disclosed |
| CN-101464299-A | Kalium ion diagnosis/measuring reagent kit and kalium ion concentration determination method | SUZHOU ANJ BIOTECH CO LTD (CN) | 2009-06-24 | — | — | CN | disclosed |
| US-20090137734-A1 | Aqueous Dispersions Of Polyurethane/Acrylic Hybrid Compositions | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2009-05-28 | — | — | US | disclosed |
| WO-2009020582-A1 | METHOD FOR TREATING A PULMONARY DISEASE STATE IN MAMMALS BY UP OR DOWN REGULATING INDIGENOUS IN VIVO LEVELS OF INFLAMMATORY AGENTS IN MAMMALIAN CELLS | CELLULAR SCIENCES, INC. (US) | 2009-02-12 | — | — | WO | disclosed |
| EP-1838837-A4 | RECOMBINANT MICROORGANISMS FOR INCREASED PRODUCTION OF ORGANIC ACIDS | MICHIGAN BIOTECH INST (US) | 2009-01-14 | — | — | EP | disclosed |
| US-20080305533-A1 | Recombinant Microorganisms For Increased Production of Organic Acids | ORACLE INTERNATIONAL CORPORATION (US) | 2008-12-11 | — | — | US | disclosed |
| EP-1855721-A1 | METHOD AND COMPOSITION FOR TREATING MAMMALIAN DISEASES AND INJURIES CAUSED BY THE OVER-EXPRESSION OF PEROXYNITRITE | North Cell Pharmaceutical, Inc. (US) | 2007-11-21 | — | — | EP | disclosed |
| EP-1838837-A2 | RECOMBINANT MICROORGANISMS FOR INCREASED PRODUCTION OF ORGANIC ACIDS | MICHIGAN BIOTECHNOLOGY INSTITUTE (US) | 2007-10-03 | — | — | EP | disclosed |
| WO-2007038524-A2 | COCRYSTALLIZATION METHODS | SSCI, INC. (US) | 2007-04-05 | — | — | WO | disclosed |
| WO-2006086643-A1 | METHOD AND COMPOSITION FOR TREATING MAMMALIAN DISEASES AND INJURIES CAUSED BY THE OVER-EXPRESSION OF PEROXYNITRITE | NORTH CELL PHARMACEUTICAL, INC. (US) | 2006-08-17 | — | — | WO | disclosed |
| WO-2006083410-A2 | RECOMBINANT MICROORGANISMS FOR INCREASED PRODUCTION OF ORGANIC ACIDS | MICHIGAN BIOTECHNOLOGY INSTITUTE (US) | 2006-08-10 | — | — | WO | disclosed |
| WO-2006060445-A2 | METHODS FOR FORMULATING AND CUSTOMIZING A MICRONUTRIENT SUPPLEMENT | METAMETRIX, INC. (US) | 2006-06-08 | — | — | WO | disclosed |
| EP-0796107-B1 | SUNSCREEN-WOUND HEALING COMPOSITION | WARNER LAMBERT CO (US) | 2003-01-08 | — | — | EP | disclosed |
| EP-0874984-A4 | ELECTROCHEMICAL BIOSENSOR TEST STRIP | ROCHE DIAGNOSTICS GMBH (DE) | 2000-05-10 | — | — | EP | disclosed |
| EP-0973938-A4 | THE USE OF NADPH AND NADH ANALOGS IN THE MEASUREMENT OF ENZYME ACTIVITIES AND METABOLITES | SPECIALTY ASSAYS INC (US) | 2000-04-26 | — | — | EP | disclosed |
| EP-0973938-A1 | THE USE OF NADPH AND NADH ANALOGS IN THE MEASUREMENT OF ENZYME ACTIVITIES AND METABOLITES | Specialty Assays, Inc. (US) | 2000-01-26 | — | — | EP | disclosed |
| WO-1999063103-A1 | YEAST-BASED PROCESS FOR PRODUCTION OF L-PAC | VICTORIA UNIVERSITY OF TECHNOLOGY (AU) | 1999-12-09 | — | — | WO | disclosed |
| EP-0920529-A1 | METHOD OF AND GROWTH MEDIUM FOR DETECTING MICRO-ORGANISMS IN A SAMPLE | The University of Lincolnshire & Humberside (GB) | 1999-06-09 | — | — | EP | disclosed |
| EP-0874984-A1 | ELECTROCHEMICAL BIOSENSOR TEST STRIP | BOEHRINGER MANNHEIM CORPORATION (US) | 1998-11-04 | — | — | EP | disclosed |
| WO-1998033936-A1 | THE USE OF NADPH AND NADH ANALOGS IN THE MEASUREMENT OF ENZYME ACTIVITIES AND METABOLITES | SPECIALTY ASSAYS, INC. (US) | 1998-08-06 | — | — | WO | disclosed |
| WO-1998007882-A1 | METHOD OF AND GROWTH MEDIUM FOR DETECTING MICRO-ORGANISMS IN A SAMPLE | THE UNIVERSITY OF LINCOLNSHIRE & HUMBERSIDE (GB) | 1998-02-26 | — | — | WO | disclosed |
| WO-1997041848-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING ALPHA-KETO CARBOXYLATES | THE GOVERNMENT OF THE UNITED STATES, REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1997-11-13 | — | — | WO | disclosed |
| US-5674912-A | COMPOSITION FOR MINIMIZING AND TREATING SUNBURN DAMAGE CONTAINING SUNSCREEN AGENT, ANTIINFLAMMATORY AGENT, WOUND HEALING COMPOSITION INCLUDING PYRUVIC ACID COMPOUND, ANTIOXIDANT, MIXTURE OF SATURATED AND UNSATURATED FATTY ACIDS | WARNER-LAMBERT COMPANY (US) | 1997-10-07 | — | — | US | disclosed |
| US-5663208-A | PYRUVIC ACID COMPPOUNDS, ANTIOXIDANTS AND FATTY ACIDS | WARNER-LAMBERT COMPANY (US) | 1997-09-02 | — | — | US | disclosed |
| US-5646190-A | TRETINOIN, PYRUVATE, ANTIOXIDANT, FATTY ACIDS | WARNER-LAMBERT COMPANY (US) | 1997-07-08 | — | — | US | disclosed |
| US-5614561-A | PYRUVIC ACID AND DERIVATIVES, FATTY ACID, TOPICAL | WARNER-LAMBERT COMPANY (US) | 1997-03-25 | — | — | US | disclosed |
| WO-1997002487-A1 | ELECTROCHEMICAL BIOSENSOR TEST STRIP | BOEHRINGER MANNHEIM CORPORATION (US) | 1997-01-23 | — | — | WO | disclosed |
| EP-0751997-A1 | DNA ENCODING ENZYMES OF THE GLYCOLITIC PATHWAY FOR USE IN ALCOHOL PRODUCING YEAST | WHITBREAD PLC (GB) | 1997-01-08 | — | — | EP | disclosed |
| WO-1995025799-A1 | DNA ENCODING ENZYMES OF THE GLYCOLITIC PATHWAY FOR USE IN ALCOHOL PRODUCING YEAST | WHITBREAD PLC (GB) | 1995-09-28 | — | — | WO | disclosed |
| EP-0505494-A4 | REDOX MEDIATOR REAGENT AND BIOSENSOR | — | 1993-10-06 | — | — | EP | disclosed |
| EP-0505494-A1 | REDOX MEDIATOR REAGENT AND BIOSENSOR. | BOEHRINGER MANNHEIM CORP (US) | 1992-09-30 | — | — | EP | disclosed |
| WO-1991009139-A1 | REDOX MEDIATOR REAGENT AND BIOSENSOR | BOEHRINGER MANNHEIM CORPORATION (US) | 1991-06-27 | — | — | WO | disclosed |
| WO-1991005063-A1 | HALOPEROXIDASE ACID OPTIMUM CHEMILUMINESCENCE ASSAY SYSTEM | EXOXEMIS, INC. (US) | 1991-04-18 | — | — | WO | disclosed |
| US-4629690-A | COMPETITIVE PROTEIN BINDING USING A SECOND ENZYME RELATED TO THE FIRST BY THE PRODUCT OF ONE BEING THE SUBSTRATE OF THE OTHER | SYNTEX (U.S.A.) INC. (US) | 1986-12-16 | — | — | US | disclosed |
| US-3956069-A | NICOTINAMIDE-ADENINE DINUCLEOTIDE | ABBOTT LABORATORIES (US) | 1976-05-11 | — | — | US | disclosed |
| US-3956069-A | NICOTINAMIDE-ADENINE DINUCLEOTIDE | ABBOTT LABORATORIES (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (27 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110003758-A1 | Inhibitors of Glycolysis Useful In the Treatment of Brain Tumors | PDK2, G6PD, PCK2 | TSHR 3744/4885FFAR3 3841/4885THPO 2764/4885 |
| US-11530190-B2 | Compounds for treating mitochondrial disease | TFAM, MFN2, CPT2 | TSHR 4550/4885FFAR3 622/4885THPO 2979/4885 |
| US-20110172312-A1 | TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES | MTCH2, NDUFA3, NDUFS3 | TSHR 3830/4885FFAR3 3477/4885THPO 1459/4885 |
| US-20110218208-A1 | 2-HETEROCYCLYLAMINOALKYL-(P-QUINONE) DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES | NQO1, PC, TXNRD2 | TSHR 4409/4885FFAR3 4141/4885THPO 3313/4885 |
| US-11938101-B2 | Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide | HADHA, ACAA2, HOGA1 | TSHR 3987/4885FFAR3 373/4885THPO 4879/4885 |
| US-20220265604-A1 | Treatment of mitochondrial diseases | NDUFAB1, UQCRC1, UQCRC2 | TSHR 3977/4885FFAR3 3903/4885THPO 2779/4885 |
| US-11840497-B2 | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | FH, NLN, ACAA2 | TSHR 2679/4885FFAR3 446/4885THPO 4741/4885 |
| US-20110086103-A1 | NOVEL MANDELATE SALT OF FESOTERODINE | BPHL, RAB27A, RPS27A | TSHR 1173/4885FFAR3 610/4885THPO 1064/4885 |
| US-11285130-B2 | Treatment of mitochondrial diseases | NDUFAB1, UQCRC1, UQCRC2 | TSHR 3977/4885FFAR3 3903/4885THPO 2779/4885 |
| US-20240390321-A1 | Treatment of mitochondrial diseases | NDUFAB1, UQCRC1, UQCRC2 | TSHR 3977/4885FFAR3 3903/4885THPO 2779/4885 |
| US-20230002324-A1 | NAPHTHOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS | NFE2L2, AIFM2, GPX4 | TSHR 3583/4885FFAR3 2878/4885THPO 1171/4885 |
| US-20230364029-A1 | POLYMORPHIC FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)BUTANAMIDE | HADHA, ACAA2, HOGA1 | TSHR 3987/4885FFAR3 373/4885THPO 4879/4885 |
| US-20110160151-A1 | Novel Acetates of 2-Deoxy Monosaccharides with Anticancer Activity | HK2, ALDOA, HK1 | TSHR 4428/4885FFAR3 646/4885THPO 1973/4885 |
| US-20240059735-A1 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES | MTPN, CKMT1A; CKMT1B, TFAM | TSHR 4021/4885FFAR3 3587/4885THPO 4455/4885 |
| US-10576077-B2 | Pharmaceutical salt forms of Cepharanthine and Tetrandrine | TPMT, HPRT1, DPYD | TSHR 3040/4885FFAR3 2669/4885THPO 162/4885 |
| US-20110065622-A1 | NOVEL NITRILE AND AMIDOXIME COMPOUNDS AND METHODS OF PREPARATION FOR SEMICONDUCTOR PROCESSING | TNNI3K, TNK1, NIT2 | TSHR 1915/4885FFAR3 4706/4885THPO 1276/4885 |
| US-20110263720-A1 | SYNTHESIS OF ALPHA-TOCOPHEROLQUINONE DERIVATIVES, AND METHODS OF USING THE SAME | TTPA, VKORC1, VKORC1L1 | TSHR 1851/4885FFAR3 3797/4885THPO 372/4885 |
| US-20220133648-A1 | TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES | MTCH2, NDUFA3, NDUFS3 | TSHR 3830/4885FFAR3 3477/4885THPO 1459/4885 |
| US-11304914-B2 | Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide | ACAA2, HADHA, HOGA1 | TSHR 4194/4885FFAR3 335/4885THPO 4882/4885 |
| US-20180303823-A1 | PHARMACEUTICAL SALT FORMS OF CEPHARANTHINE AND TETRANDRINE | TPMT, HPRT1, DPYD | TSHR 3040/4885FFAR3 2669/4885THPO 162/4885 |
| US-11680034-B2 | Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders | NFE2L2, NQO1, ALDH2 | TSHR 2889/4885FFAR3 1542/4885THPO 2612/4885 |
| US-20110124679-A1 | 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES | NQO1, TXNRD2, MT-ND2 | TSHR 4304/4885FFAR3 3903/4885THPO 2659/4885 |
| US-20260034177-A1 | HUMAN FUNCTIONAL CORNEAL ENDOTHELIAL CELL AND APPLICATION THEREOF | EPCAM, CD44, SLC17A5 | TSHR 2582/4885FFAR3 3404/4885THPO 484/4885 |
| US-20160280716-A1 | PHARMACEUTICAL SALT FORMS OF CEPHARANTHINE AND TETRANDRINE | SLC7A1, SLC6A6, HPRT1 | TSHR 1842/4885FFAR3 1677/4885THPO 37/4885 |
| US-20220265578-A1 | POLYMORPHIC AND AMORPHOUS FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)BUTANAMIDE | ACAA2, HADHA, HOGA1 | TSHR 4194/4885FFAR3 335/4885THPO 4882/4885 |
| US-20220055975-A1 | REDOX-ACTIVE THERAPEUTICS FOR TREATMENT OF MITOCHONDRIAL DISEASES AND OTHER CONDITIONS AND MODULATION OF ENERGY BIOMARKERS | ECHS1, FH, ACAA2 | TSHR 1524/4885FFAR3 772/4885THPO 3969/4885 |
| US-20110046219-A1 | (HET)ARYL-P-QUINONE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES | FH, ECHS1, NDUFS6 | TSHR 2353/4885FFAR3 606/4885THPO 4319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.